Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 84 results found. Search for [ Natco Pharma ]

Results 1 to 21 of 84
BusinessToday.In
October 15, 2018
The Natco Pharma stock closed 5.57% or 37 points higher at 717.05 on the BSE. The stock has been gaining for the last two days and has risen 8.36% during the period. The stock hit an intra day high of 733.70 (8.02%) in trade today.


PTI
October 15, 2018



E Kumar Sharma
New Delhi, July 18, 2018
Those within the pharma industry see a couple of messages coming across from the movie.


P.B. Jayakumar
New Delhi, April 30, 2018
Drug companies are moving up the value chain, transforming into complex generic manufacturers with high end R&D facilities.


BusinessToday.In
New Delhi, April 27, 2018
To begin with, according to industry insiders, rising crude is putting pressure on rupee already stressed by widening fiscal deficit.


Sameer Bhardwaj
New Delhi, February 7, 2018
After making record highs in January 2018, the stock markets have entered a bear phase after Union Budget 2018.


BusinessToday.in
February 7, 2018
While the Sensex closed 113 points lower to 34,082 level, the Nifty fell 21 points to 10,476 level. Banking stocks led the fall with BSE bankex losing 125 points to 29,072 level.


PTI
February 6, 2018



Arpita Mukherjee
January 13, 2018
As the exhilarating day of BT MindRush was coming to a close, it was time to honour the best corporate leaders. The chief guest at the event, Jayant Sinha, Union Minister of State for Civil Aviation, handed over the awards to the winners.


BusinessToday.in
January 13, 2018
Business Today will host the fifth edition of MindRush - India Today Group's annual flagship business event. The one-day conference will take place on January 13 at St Regis, Mumbai. Here are the highlights.


E. Kumar Sharma
New Delhi, January 10, 2018
By following the strategy of doing a few things well, V.C. Nannapaneni has helped Natco Pharma carve out a space for itself.


Team BT
New Delhi, January 10, 2018
Taking calculated risks and thinking long term separated the best CEOs from the good ones.


E Kumar Sharma
New Delhi, December 19, 2017
On December 7th, Mylan launched 'HepBest', which it called, \"the first drug approved in eight years for management of chronic Hepatitis B infection in India.\" 


PTI
December 14, 2017



E. Kumar Sharma
Delhi, April 1, 2017
Leading Indian pharmaceutical companies are facing competition in the US from relatively smaller firms back home.


E Kumar Sharma
June 3, 2016
\"Real, meaningful progress remains elusive, and recent signals indicate backsliding in key areas. For instance, India just released its long-awaited National Intellectual Property Rights Policy, which falls far short of industry expectations.\"


PTI
Mumbai, March 31, 2016
Heavy crash in commodity prices, first Fed rate hike in nearly a decade, global slowdown, especially in China, and slower pace of key domestic reforms pulled Sensex by 2,615.63 points during the year.


PTI
Mumbai, March 29, 2016
In a see-saw trading, the benchmark BSE Sensex edged lower by 66 points to end at about two-week low of 24,900.46 while NSE Nifty fell by 18 points to slip below the 7,600-mark.


Aprajita Sharma
New Delhi, January 5, 2016
Analysts believe first half of 2016 may mirror bearish trend of 2015, but benchmark indices may begin to log gains in the second half of 2016.


By David Singh Grewal and Amy Kapczynski
Delhi, December 28, 2015
Yale Law School's associate professor David Singh Grewal (right), a specialist in IP law and biotechnology and Professor Amy Kapczynski explain how to make drugs-for-all a national priority.


PAGES 1 OF 5  12345